Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Williams

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
Diabetes Care|September 28, 2005
The prevalence of the metabolic syndrome did not increase in Mexico City between 1990-1992 and 1997-1999 despite more central obesityCarlos Lorenzo, Ken Williams, Clicerio Gonzalez-Villalpando, et al.
Journal of Clinical Lipidology|December 3, 2010
Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol?Allan Sniderman, Matt McQueen, John Contois, et al.
Journal of Clinical Lipidology|December 3, 2010
When is equal not equal?Allan D Sniderman, Ken Williams, Matthew J McQueen, et al.
Diabetes Care|March 27, 2007
What is the best predictor of future type 2 diabetes?Muhammad A Abdul-Ghani, Ken Williams, Ralph A DeFronzo, et al.
Diabetes|March 12, 2008
Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance testAndreas Festa, Ken Williams, Anthony J G Hanley, et al.
Circulation|October 20, 2004
Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis StudyNaveed Sattar, Ken Williams, Allan D Sniderman, et al.
Diabetes Care|June 28, 2002
Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart StudyAnthony J G Hanley, Ken Williams, Michael P Stern, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2010
Cardiovascular death in dialysis patients: lessons we can learn from AURORAAllan D Sniderman, Amirreza Solhpour, Ahsan Alam, et al.
Diabetes|March 29, 2006
The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis StudyAndreas Festa, Ken Williams, Ralph D'Agostino, et al.
Diabetes Care|October 28, 2003
The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart studyCarlos Lorenzo, Mayor Okoloise, Ken Williams, et al.
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Diabetes Care|September 28, 2005
The prevalence of the metabolic syndrome did not increase in Mexico City between 1990-1992 and 1997-1999 despite more central obesityCarlos Lorenzo, Ken Williams, Clicerio Gonzalez-Villalpando, et al.
Journal of Clinical Lipidology|December 3, 2010
Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol?Allan Sniderman, Matt McQueen, John Contois, et al.
Journal of Clinical Lipidology|December 3, 2010
When is equal not equal?Allan D Sniderman, Ken Williams, Matthew J McQueen, et al.
Diabetes Care|March 27, 2007
What is the best predictor of future type 2 diabetes?Muhammad A Abdul-Ghani, Ken Williams, Ralph A DeFronzo, et al.
Diabetes|March 12, 2008
Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance testAndreas Festa, Ken Williams, Anthony J G Hanley, et al.
Circulation|October 20, 2004
Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis StudyNaveed Sattar, Ken Williams, Allan D Sniderman, et al.
Diabetes Care|June 28, 2002
Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart StudyAnthony J G Hanley, Ken Williams, Michael P Stern, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2010
Cardiovascular death in dialysis patients: lessons we can learn from AURORAAllan D Sniderman, Amirreza Solhpour, Ahsan Alam, et al.
Diabetes|March 29, 2006
The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis StudyAndreas Festa, Ken Williams, Ralph D'Agostino, et al.
Diabetes Care|October 28, 2003
The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart studyCarlos Lorenzo, Mayor Okoloise, Ken Williams, et al.
Pageof 11